Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Inorg Biochem ; 256: 112550, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38599004

RESUMEN

Cisplatin remains the most widely used chemotherapeutic agent in cancer treatment; however, its inherent drawbacks have fueled the development of novel metalloanticancer drugs. In this study, two novel Cu(II) complexes (Cu1 and Cu2) were designed and synthesized. Notably, these Cu(II) complexes showed higher cytotoxicity against HL-7402 cells than cisplatin. Moreover, Cu(II) complexes significantly inhibited liver cancer growth in a xenograft model. A mechanism study revealed that the Cu(II) complexes reduced the mitochondrial membrane potential of cancer cells, produced excessive reactive oxygen species (ROS), induced mitochondrial DNA (mtDNA) damage, and ultimately facilitated cancer cell apoptosis.


Asunto(s)
Antineoplásicos , Apoptosis , Complejos de Coordinación , Cobre , Daño del ADN , ADN Mitocondrial , Neoplasias Hepáticas , Mitocondrias , Especies Reactivas de Oxígeno , Humanos , Cobre/química , Cobre/farmacología , Apoptosis/efectos de los fármacos , Neoplasias Hepáticas/tratamiento farmacológico , Neoplasias Hepáticas/patología , Neoplasias Hepáticas/metabolismo , Animales , Daño del ADN/efectos de los fármacos , Complejos de Coordinación/farmacología , Complejos de Coordinación/química , Complejos de Coordinación/síntesis química , Antineoplásicos/farmacología , Antineoplásicos/química , Antineoplásicos/síntesis química , Ratones , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , ADN Mitocondrial/metabolismo , ADN Mitocondrial/genética , Especies Reactivas de Oxígeno/metabolismo , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Línea Celular Tumoral , Hidrazonas/farmacología , Hidrazonas/química , Hidrazonas/síntesis química , Ensayos Antitumor por Modelo de Xenoinjerto , Ratones Desnudos , Ratones Endogámicos BALB C
2.
Ginekol Pol ; 90(10): 596-603, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31686417

RESUMEN

OBJECTIVES: Pre-eclampsia (PE) affects many women worldwide and remains the leading cause of morbidity and mortality in neonatal and maternal settings. Abnormal expression of placental microRNAs (miRNAs) may be associated with PE. MATERIAL AND METHODS: This study was conducted to the relationship between IGF1 and the expression spectrum of miRNA in the placenta of preeclampsia patient. The expression of miRNA in placental tissue was compared between pre-eclampsia (n = 6) and normal pregnant women (n = 5) miRNA targets were studied by computer simulation and functional assays. The role of miRNA was verified in trophoblast cell lines by apoptosis assay and invasion assay. RESULTS: There was a significant increase in miRNAs in the placenta of women with pre-eclampsia compared with patients with normal pregnancy. Luciferase assay confirmed direct regulation of miRNA. CONCLUSIONS: The expression of IGF1 and miRNA was significantly increased in the placenta of patients with pre-eclampsia.


Asunto(s)
Factor I del Crecimiento Similar a la Insulina/genética , MicroARNs/genética , Placenta/metabolismo , Preeclampsia/genética , Análisis por Conglomerados , Femenino , Humanos , Factor I del Crecimiento Similar a la Insulina/metabolismo , MicroARNs/metabolismo , Placenta/química , Preeclampsia/epidemiología , Preeclampsia/metabolismo , Embarazo , Transducción de Señal/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA